A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Of The Analgesic Efficacy And Safety Of Tanezumab In Patients With Chronic Pancreatitis.
Phase of Trial: Phase II
Latest Information Update: 29 Aug 2012
At a glance
- Drugs Tanezumab (Primary)
- Indications Abdominal pain
- Focus Therapeutic Use
- 13 Apr 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 14 Mar 2011 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Feb 2011 Planned end date changed from 1 Sep 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.